Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Loans - Net Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Perspective Therapeutics (CATX) Goodwill (2023 - 2024)

Historic Goodwill for Perspective Therapeutics (CATX) over the last 2 years, with Q3 2024 value amounting to $24.1 million.

Perspective Therapeutics' Goodwill fell 1178.3% to $24.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.1 million, marking a year-over-year decrease of 1178.3%. This contributed to the annual value of $24.1 million for FY2023, which is N/A changed from last year.
As of Q3 2024, Perspective Therapeutics' Goodwill stood at $24.1 million, which was down 1178.3% from $24.1 million recorded in Q2 2024.
Perspective Therapeutics' Goodwill's 5-year high stood at $27.3 million during Q1 2023, with a 5-year trough of $24.1 million in Q4 2023.